-
1
-
-
33747890096
-
Regulation of genotoxic and carcinogenic impurities in drug substances and products
-
DOI 10.1016/j.trac.2006.06.004, PII S0165993606001270, Drug-Impurity Profiling
-
T McGovern D Jacobsen-Kram 2006 Trends Anal Chem 25 790 10.1016/j.trac.2006.06.004 1:CAS:528:DC%2BD28XoslCjsLs%3D (Pubitemid 44291461)
-
(2006)
TrAC - Trends in Analytical Chemistry
, vol.25
, Issue.8
, pp. 790-795
-
-
McGovern, T.1
Jacobson-Kram, D.2
-
2
-
-
33645840463
-
-
10.1016/j.yrtph.2005.12.001
-
L Muller RJ Mauthe CM Riley MM Andino D De Antonis C Beels J DeGeorge AGM De Knaep D Ellison JA Fegerland R Frank B Fitschel S Galloway E Harpur CDN Humfrey AS Jacks N Jagota J Mackinnon G Mohan DK Ness MR O'Donovan MD Smith G Vudathala L Yotti 2006 Regul Toxicol Pharmacol 44 198 10.1016/j.yrtph.2005.12. 001
-
(2006)
Regul Toxicol Pharmacol
, vol.44
, pp. 198
-
-
Muller, L.1
Mauthe, R.J.2
Riley, C.M.3
Andino, M.M.4
De Antonis, D.5
Beels, C.6
Degeorge, J.7
De Knaep, A.G.M.8
Ellison, D.9
Fegerland, J.A.10
Frank, R.11
Fitschel, B.12
Galloway, S.13
Harpur, E.14
Humfrey, C.D.N.15
Jacks, A.S.16
Jagota, N.17
MacKinnon, J.18
Mohan, G.19
Ness, D.K.20
O'Donovan, M.R.21
Smith, M.D.22
Vudathala, G.23
Yotti, L.24
more..
-
4
-
-
65349091521
-
-
10.2174/157341208786306199 1:CAS:528:DC%2BD1cXhsVart7bP
-
D Bartos S Görög 2008 Current Pharmaceutical Analysis 4 215 10.2174/157341208786306199 1:CAS:528:DC%2BD1cXhsVart7bP
-
(2008)
Current Pharmaceutical Analysis
, vol.4
, pp. 215
-
-
Bartos, D.1
Görög, S.2
-
7
-
-
55849151593
-
-
European Medicines Evaluation Agency, Committee for Medicinal Products for Human Use CPMP/SWP/5199/02, London, 28 June 2006
-
European Medicines Evaluation Agency, Committee for Medicinal Products for Human Use, Guideline on the limits of genotoxic impurities, CPMP/SWP/5199/02, London, 28 June 2006 ( http://www.emea.europa.eu/pdfs/human/ swp/519902en.pdf )
-
Guideline on the Limits of Genotoxic Impurities
-
-
-
8
-
-
76749103090
-
-
Guidance for Industry US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER), December
-
Guidance for Industry. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches. US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER), December 2008
-
(2008)
Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches
-
-
-
10
-
-
36849014367
-
Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs)
-
DOI 10.1016/j.jpba.2007.10.013, PII S0731708507005675
-
DP Elder A Teasdale AM Lipczynski 2008 J Pharm Biomed Anal 46 1 10.1016/j.jpba.2007.10.013 1:CAS:528:DC%2BD2sXhsVWjtr%2FK (Pubitemid 350225647)
-
(2008)
Journal of Pharmaceutical and Biomedical Analysis
, vol.46
, Issue.1
, pp. 1-8
-
-
Elder, D.P.1
Teasdale, A.2
Lipczynski, A.M.3
-
11
-
-
0029738238
-
Gas chromatographic/mass spectrometric analysis of methyl methanesulphonate and ethyl methanesulphonate in the bismesylate salt of DPI 201-106, a positive inotropic agent for the treatment of heart failure
-
DOI 10.1002/(SICI)1096-9888(199608)31:8<867::AID-JMS362>3.0.CO;2-Q
-
HRG Ramijt MM Singh AB Coddington 1996 J Mass Spectrom 31 867 10.1002/(SICI)1096-9888(199608)31:8<867::AID-JMS362>3.0.CO;2-Q (Pubitemid 26258964)
-
(1996)
Journal of Mass Spectrometry
, vol.31
, Issue.8
, pp. 867-872
-
-
Ramjit, H.G.1
Singh, M.M.2
Coddington, A.B.3
-
13
-
-
35349026723
-
A generic approach for the determination of residues of alkylating agents in active pharmaceutical ingredients by in situ derivatization-headspace-gas chromatography-mass spectrometry
-
DOI 10.1016/j.jpba.2007.07.017, PII S0731708507004104
-
R Alzaga RW Ryan K Taylor-Worth AM Lipczynski R Szucs P Sandra 2007 J Pharm Biomed Anal 45 472 10.1016/j.jpba.2007.07.017 1:CAS:528:DC%2BD2sXhtF2ru7bL (Pubitemid 47595429)
-
(2007)
Journal of Pharmaceutical and Biomedical Analysis
, vol.45
, Issue.3
, pp. 472-479
-
-
Alzaga, R.1
Ryan, R.W.2
Taylor-Worth, K.3
Lipczynski, A.M.4
Szucs, R.5
Sandra, P.6
-
14
-
-
58249094973
-
-
10.1016/j.jpba.2008.09.028 1:CAS:528:DC%2BD1MXntlyhsA%3D%3D
-
K Jacq E Delaney A Teasdale S Eyley K Taylor-Worth AM Lipczynski VD Reif DP Elder KL Facchine S Golec RS Oestrich P Sandra F David 2008 J Pharm Biomed Anal 48 1339 10.1016/j.jpba.2008.09.028 1:CAS:528:DC%2BD1MXntlyhsA%3D%3D
-
(2008)
J Pharm Biomed Anal
, vol.48
, pp. 1339
-
-
Jacq, K.1
Delaney, E.2
Teasdale, A.3
Eyley, S.4
Taylor-Worth, K.5
Lipczynski, A.M.6
Reif, V.D.7
Elder, D.P.8
Facchine, K.L.9
Golec, S.10
Oestrich, R.S.11
Sandra, P.12
David, F.13
-
15
-
-
23944465208
-
Determination of methyl and ethyl esters of methanesulfonic, benzenesulfonic and p-toluenesulfonic acids in active pharmaceutical ingredients by solid-phase microextraction (SPME) coupled to GC/SIM-MS
-
DOI 10.1016/j.jpba.2005.04.037, PII S0731708505003043
-
I Colon SM Richoll 2005 J Pharm Biomed Anal 39 477 10.1016/j.jpba.2005. 04.037 1:CAS:528:DC%2BD2MXpsVCnt7s%3D (Pubitemid 41196052)
-
(2005)
Journal of Pharmaceutical and Biomedical Analysis
, vol.39
, Issue.3-4
, pp. 477-485
-
-
Colon, I.1
Richoll, S.M.2
-
17
-
-
23944435696
-
Development and validation of a sensitive GC-MS method for the determination of trace levels of an alkylating reagent in a β-lactam active pharmaceutical ingredient
-
DOI 10.1016/j.jpba.2005.04.042, PII S0731708505003109
-
H Li GW Sluggett 2005 J Pharm Biomed Anal 39 486 10.1016/j.jpba.2005.04. 042 1:CAS:528:DC%2BD2MXpsVCnt7g%3D (Pubitemid 41196053)
-
(2005)
Journal of Pharmaceutical and Biomedical Analysis
, vol.39
, Issue.3-4
, pp. 486-494
-
-
Li, H.1
Sluggett, G.W.2
-
18
-
-
0028927371
-
-
10.1016/0731-7085(95)01307-7 1:CAS:528:DyaK2MXltlOgs7w%3D
-
S Klick 1995 J Pharm Biomed Anal. 13 563 10.1016/0731-7085(95)01307-7 1:CAS:528:DyaK2MXltlOgs7w%3D
-
(1995)
J Pharm Biomed Anal.
, vol.13
, pp. 563
-
-
Klick, S.1
-
20
-
-
84889482886
-
-
R.J. Smith M.L. Webb (eds). Blackwell Oxford. 10.1002/9780470988749.ch4
-
Skett P (2007) In: Smith RJ, Webb ML (eds) Analysis of drug impurities. Blackwell, Oxford, pp 82-123
-
(2007)
Analysis of Drug Impurities
, pp. 82-123
-
-
Skett, P.1
-
21
-
-
59049102650
-
-
10.1016/j.jpba.2008.11.009 1:CAS:528:DC%2BD1MXhs1altr4%3D
-
M Sun L Bai DQ Liu 2009 J Pharm Biomed Anal 49 529 10.1016/j.jpba.2008. 11.009 1:CAS:528:DC%2BD1MXhs1altr4%3D
-
(2009)
J Pharm Biomed Anal
, vol.49
, pp. 529
-
-
Sun, M.1
Bai, L.2
Liu, D.Q.3
-
23
-
-
76749112232
-
-
LC-GC, December 2009
-
David F, Jacq K, Vanhoenacker G, Sandra P, Baker A, (2009) LC-GC, December 2009
-
(2009)
-
-
David, F.1
Jacq, K.2
Vanhoenacker, G.3
Sandra, P.4
Baker, A.5
-
24
-
-
34250528902
-
-
10.1007/BF02259005
-
D Deans 1968 Chromatographia 1 18 10.1007/BF02259005
-
(1968)
Chromatographia
, vol.1
, pp. 18
-
-
Deans, D.1
-
26
-
-
0037485399
-
-
L. Mondello A.C. Lewis K.D. Bartle (eds). Wiley West Sussex, England
-
Lewis AC (2002) In: Mondello L, Lewis AC, Bartle KD (eds) Multidimensional chromatography. Wiley, West Sussex, England, pp 47-75
-
(2002)
Multidimensional Chromatography
, pp. 47-75
-
-
Lewis, A.C.1
-
28
-
-
76749087697
-
-
Agilent Technologies Publication Number: 5989-9384EN, 2008
-
Agilent Technologies Publication Number: 5989-9384EN, 2008
-
-
-
-
29
-
-
76749144838
-
-
Agilent Technologies publication number 5990-3576EN
-
David F, Klee MS (2009) Agilent Technologies publication number 5990-3576EN
-
(2009)
-
-
David, F.1
Klee, M.S.2
-
31
-
-
0000454418
-
-
10.1021/ac971141v 1:CAS:528:DyaK1cXlvVKrs7s%3D
-
LM Blumberg MS Klee 1998 Anal Chem 70 3828 10.1021/ac971141v 1:CAS:528:DyaK1cXlvVKrs7s%3D
-
(1998)
Anal Chem
, vol.70
, pp. 3828
-
-
Blumberg, L.M.1
Klee, M.S.2
|